CTRP portal: a critical resource for advancing the discovery of potential cancer drugs matched to the patient populations most likely to benefit from them

"The Broad Institute’s Center for the Science of Therapeutics today announced the launch of its Cancer Therapeutics Response Portal (CTRP) – a critical resource for advancing the discovery of potential cancer drugs matched to the patient populations most likely to benefit from them. The portal, which will serve as a public resource for researchers worldwide, contains more than 70,000 connections between compound sensitivities and genetic or lineage features of cancer cell lines – creating a dataset that researchers can use to look for therapeutically exploitable vulnerabilities in different cancer types." (Source)

Compounds point the way to cancer’s dependencies: Public portal launched to identify therapeutic sensitivities... http://t.co/fopdsnDQcf
— Broad Institute (@broadinstitute) August 29, 2013